Fenfluramina [DCIT] en es it fr

Fenfluramina [DCIT] Brand names, Fenfluramina [DCIT] Analogs

Fenfluramina [DCIT] Brand Names Mixture

  • No information avaliable

Fenfluramina [DCIT] Chemical_Formula


Fenfluramina [DCIT] RX_link


Fenfluramina [DCIT] fda sheet

Fenfluramina [DCIT] msds (material safety sheet)

Fenfluramina [DCIT] Synthesis Reference

No information avaliable

Fenfluramina [DCIT] Molecular Weight

231.257 g/mol

Fenfluramina [DCIT] Melting Point

108-112 oC at 1.20E+01 mm Hg

Fenfluramina [DCIT] H2O Solubility

412 mg/L

Fenfluramina [DCIT] State


Fenfluramina [DCIT] LogP


Fenfluramina [DCIT] Dosage Forms

Capsule (sustained-release); Tablet

Fenfluramina [DCIT] Indication

For the management of exogenous obesity as a short-term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction.

Fenfluramina [DCIT] Pharmacology

Used to treat diabetes and obesity, Fenfluramine decreases caloric intake by increasing serotonin levels in the brain's synapses. Fenfluramine acts as a serotonin reuptake inhibitor. It also causes release of serotonin from the synaptosomes.

Fenfluramina [DCIT] Absorption

No information avaliable

Fenfluramina [DCIT] side effects and Toxicity

No information avaliable

Fenfluramina [DCIT] Patient Information

No information avaliable

Fenfluramina [DCIT] Organisms Affected

Humans and other mammals